Roche Provides Molecular Testing Solutions To Identify & Differentiate SARS-CoV-2 Omicron Variants
SOUTH SAN FRANCISCO (dpa-AFX) - Roche and its subsidiary, Tib Molbiol, confirmed that it has tests for research use that identify the SARS-CoV-2 subvariants of concern, Omicron: BA.1, BA.1.1, BA.2
Source: finanznachrichten.de